Picture of Aceragen logo

ACGN — Aceragen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Brief: Idera Pharmaceuticals Posts Q3 Loss Per Share Of $0.11

Nov 8 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q3 LOSS PER SHARE $0.11

Source text for Eikon:  ID:nGNXNs9GS 
Further company coverage:  IDRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aceragen

See all news